Cargando…
KCNAB2 overexpression inhibits human non-small-cell lung cancer cell growth in vitro and in vivo
Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. NSCLC patients often have poor prognosis demanding urgent identification of novel biomarkers and potential therapeutic targets. KCNAB2 (regulatory beta subunit2 of voltage-gated potassium channel), encoding a...
Autores principales: | Cheng, Feng, Tang, Yu-fei, Cao, Yang, Peng, Shi-qing, Zhu, Xiao-ren, Sun, Yue, Wang, Shu-Hang, Wang, Bin, Lu, Yi-min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584983/ https://www.ncbi.nlm.nih.gov/pubmed/37852974 http://dx.doi.org/10.1038/s41420-023-01679-5 |
Ejemplares similares
-
Kcnab1 Is Expressed in Subplate Neurons With Unilateral Long-Range Inter-Areal Projections
por: Tiong, Sheena Yin Xin, et al.
Publicado: (2019) -
The Ion Channel Gene KCNAB2 Is Associated with Poor Prognosis and Loss of Immune Infiltration in Lung Adenocarcinoma
por: Lyu, Yin, et al.
Publicado: (2022) -
Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model
por: Ding, Jian, et al.
Publicado: (2022) -
H258R mutation in KCNAB3 gene in a family with genetic epilepsy and febrile seizures plus
por: Ding, Jian, et al.
Publicado: (2020) -
TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo
por: Hu, Zhongwu, et al.
Publicado: (2018)